Related Experiment Video
Updated: Aug 15, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway
Ju Ri Jung1, Hongtae Kim, Sin-Soo Jeun
1Department of Neurosurgery, The Catholic University of Korea, Seoul 137-701, Korea.
Abstract:
The neurofibromatosis type2 (NF2) tumor suppressor gene product, merlin, is structurally related to the ezrin-radixin-moesin (ERM) family of proteins that anchor the actin cytoskeleton to specific membrane proteins and participate in cell signaling. However, the basis of the tumor suppressing activity of merlin is not well understood. Previously, we identified a role of merlin as an inhibitor of the Ras-ERK signaling pathway. Recent studies have suggested that phosphorylation of merlin, as of other ERM proteins, may regulate its function. To determine whether phosphorylation of merlin affects its suppression of Ras-ERK signaling, we generated plasmids expressing full-length merlin with substitutions of serine 518, a potential phosphorylation site. A substitution that mimics constitutive phosphorylation (S518D) abrogated the ability of merlin to suppress effects of the Ras-ERK signaling pathway such as Ras-induced SRE transactivation, Elk-mediated SRE transactivation, Ras-induced ERK phosphorylation and Ras-induced focus formation. On the other hand, an S518A mutant, which mimics nonphosphorylated merlin, acted like wild type merlin. These observations show that mimicking merlin phosphorylation impairs not only growth suppression by merlin but also its inhibitory action on the Ras-ERK signaling pathway.
Insights
Phosphorylation of the neurofibromatosis type 2 (NF2) protein, merlin, impairs its tumor-suppressing activity. Mimicking merlin phosphorylation blocks its inhibition of the Ras-ERK signaling pathway and cell growth.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Merlin, the neurofibromatosis type 2 (NF2) tumor suppressor, is structurally similar to ezrin-radixin-moesin (ERM) proteins involved in cytoskeleton-actin linkage and cell signaling.
- The precise mechanism of merlin's tumor-suppressing activity remains unclear.
- Emerging evidence suggests that phosphorylation may regulate merlin function, similar to other ERM proteins.
Purpose of the Study:
- To investigate the impact of merlin phosphorylation on its tumor-suppressive functions.
- To determine if merlin's inhibition of the Ras-ERK signaling pathway is modulated by its phosphorylation status.
Main Methods:
- Generated expression plasmids for full-length merlin with serine 518 substitutions.
- Created a phosphomimetic mutant (S518D) and a non-phosphorylatable mutant (S518A).
- Assessed the effects of these merlin mutants on Ras-ERK signaling components and cellular transformation.
Main Results:
- The S518D mutant, mimicking constitutive phosphorylation, abolished merlin's ability to suppress Ras-ERK pathway effects.
- These suppressed effects included Ras-induced SRE transactivation, Elk-mediated SRE transactivation, ERK phosphorylation, and focus formation.
- The S518A mutant, mimicking non-phosphorylation, exhibited wild-type merlin activity.
Conclusions:
- Phosphorylation of merlin at serine 518 is critical for its tumor-suppressive function.
- Mimicking merlin phosphorylation abrogates its inhibitory effect on the Ras-ERK signaling pathway.
- These findings highlight the regulatory role of merlin phosphorylation in controlling cell growth and signaling.
Related Concept Videos
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a superfamily...
Amplifying Signals via Enzymatic Cascade
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

